Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clinical Study of Microdosing Carboplatin in Lung or Bladder Cancer

This study has been terminated.
(Contract ended)
Sponsor:
Collaborators:
Lawrence Livermore National Laboratory
National Institutes of Health (NIH)
Information provided by (Responsible Party):
University of California, Davis
ClinicalTrials.gov Identifier:
NCT01261299
First received: December 9, 2010
Last updated: November 8, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: November 2018
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)